Elevance Health, Inc. ELV
413.75 USD +0.15 (+0.04%)
At closeNov 3, 2026, 7:43 PM EST
410.00 -3.75 -0.91%
After hours · Nov 3, 7:43 PM ET
411.47 Day range 417.39
274.84 52-week range 450.69
- YTD
- +18.03%
- 1 year
- +32.11%
Analyst view
Consensus: buy
Buy
Price target (mean) 482.38 +16.6% upside
Now 413.75
- Target (low)
- 406.00
- Target (mean)
- 482.38
- Target (high)
- 523.00
Ratings (0m) 22 15 buy · 7 hold · 0 sell
- Strong buy3
- Buy12
- Hold7
- Sell0
- Strong sell0
Recommendation trend
- This month 22
- 1 month ago 22
- 2 months ago 22
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 2.07 | 1.64 – 3.22 | 3.33 | -37.9% | 49.14B | -0.3% | 20 |
| Next quarter | 12.32 | 8.69 – 13.23 | 12.58 | -2.1% | 50.06B | +1.1% | 14 |
| Current year | 29.14 | 28.65 – 30.28 | 30.29 | -3.8% | 198.85B | +0.6% | 21 |
| Next year | 30.29 | 29.95 – 31.75 | 29.14 | +3.9% | 203.75B | +2.5% | 21 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 27, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Oct 23, 2026 | TD Cowen | Maintained | Buy | Buy |
| Oct 22, 2026 | UBS | Maintained | Buy | Buy |
| Oct 22, 2026 | Guggenheim | Maintained | Buy | Buy |
| Oct 22, 2026 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Oct 22, 2026 | RBC Capital | Maintained | Sector Perform | Sector Perform |
| Oct 22, 2026 | Barclays | Maintained | Overweight | Overweight |
| Oct 22, 2026 | Baird | Maintained | Neutral | Neutral |
| Oct 12, 2026 | Guggenheim | Maintained | Buy | Buy |
| Oct 7, 2026 | Barclays | Maintained | Overweight | Overweight |
| Jul 17, 2026 | Bernstein | Maintained | Outperform | Outperform |
| Jul 17, 2026 | Leerink Partners | Maintained | Market Perform | Market Perform |
| Jul 16, 2026 | RBC Capital | Maintained | Sector Perform | Sector Perform |
| Jul 16, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Jul 16, 2026 | Guggenheim | Maintained | Buy | Buy |
| Jul 16, 2026 | Barclays | Maintained | Overweight | Overweight |
| Jul 16, 2026 | Baird | Maintained | Neutral | Neutral |
| Jul 14, 2026 | TD Cowen | Maintained | Buy | Buy |
| Jul 14, 2026 | Truist Securities | Maintained | Buy | Buy |
| Jul 13, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Jul 9, 2026 | RBC Capital | Maintained | Sector Perform | Sector Perform |
| Jul 7, 2026 | Cantor Fitzgerald | Maintained | Overweight | Overweight |
| Jul 2, 2026 | Bernstein | Maintained | Outperform | Outperform |
| Jun 8, 2026 | Mizuho | Maintained | Outperform | Outperform |
| Jun 8, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Jun 4, 2026 | B of A Securities | Maintained | Buy | Buy |
| Jun 4, 2026 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Jun 1, 2026 | Truist Securities | Maintained | Buy | Buy |
| May 26, 2026 | Barclays | Maintained | Overweight | Overweight |
| May 22, 2026 | UBS | Maintained | Buy | Buy |
